Skip to Main Content

Paper Details

Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.
Sci Transl Med
42
2015
FLS, Joint-lining cells, RA, RPTP, RPTP decoy protein, arthritis, ezrin, fibroblast-like synoviocytes, human, joint inflammation, patients, rheumatoid arthritis, sulfate, syndecan-4, transmembrane tyrosine phosphatase, tyrosine
Author NameAffiliation
Karen M DoodyLa Jolla Institute for Allergy and Immunology
Stephanie M StanfordLa Jolla Institute for Allergy and Immunology
Cristiano SacchettiLa Jolla Institute for Allergy and Immunology
Mattias N D SvenssonLa Jolla Institute for Allergy and Immunology
Beatrix BartokUniversity of California, San Diego School of Medicine
Robert L SahUniversity of California
David L BoyleUniversity of California, San Diego School of Medicine
Maripat CorrUniversity of California, San Diego School of Medicine
Michel L TremblayRosalind and Morris Goodman Cancer Research Centre, McGill University
Gary S FiresteinUniversity of California, San Diego School of Medicine
Nunzio BottiniLa Jolla Institute for Allergy and Immunology
  • 1 - 11

Datasets

Release 1.2